RhumbLine Advisers’s Palvella Therapeutics PVLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	9,129 +493	+6%	+$51.4K	﹤0.01%	2126
2025 Q4	$904K	Sell	8,636 -1,235	-13%	-$105K	﹤0.01%	2291
2025 Q3	$619K	Sell	9,871 -85	-0.9%	-$3.79K	﹤0.01%	2550
2025 Q2	$224K	Buy	+9,956	New	+$234K	﹤0.01%	3166
2024 Q1	–	Sell	-23	Closed	-$339	–	4267
2023 Q4	$339	Hold	23	–	–	﹤0.01%	4216
2023 Q3	$556	Hold	23	–	–	﹤0.01%	4225
2023 Q2	$309	Buy	+23	New	+$1.4K	﹤0.01%	4338
2021 Q2	–	Sell	-786	Closed	-$162K	–	3121
2021 Q1	$162K	Buy	786 +1	+0.1%	+$219	﹤0.01%	2874
2020 Q4	$157K	Buy	785 +49	+7%	+$10.2K	﹤0.01%	2898
2020 Q3	$122K	Sell	736 -108	-13%	-$24.6K	﹤0.01%	2834
2020 Q2	$209K	Buy	844 +54	+7%	+$12.6K	﹤0.01%	2748
2020 Q1	$144K	Hold	790	–	–	﹤0.01%	2690
2019 Q4	$229K	Buy	790 +4	+0.5%	+$1.11K	﹤0.01%	2704
2019 Q3	$214K	Sell	786 -6	-0.8%	-$2.32K	﹤0.01%	2729
2019 Q2	$298K	Sell	792 -32	-4%	-$9.55K	﹤0.01%	2609
2019 Q1	$221K	Sell	824 -11	-1%	-$2.61K	﹤0.01%	2708
2018 Q4	$178K	Buy	835 +284	+52%	+$88.1K	﹤0.01%	2765
2018 Q3	$247K	Sell	551 -42	-7%	-$18.3K	﹤0.01%	2619
2018 Q2	$241K	Buy	593 +180	+44%	+$85.7K	﹤0.01%	2647
2018 Q1	$226K	Buy	413 +33	+9%	+$20.4K	﹤0.01%	2556
2017 Q4	$230K	Sell	380 -88	-19%	-$40.9K	﹤0.01%	2576
2017 Q3	$216K	Buy	468 +14	+3%	+$5.98K	﹤0.01%	2693
2017 Q2	$184K	Buy	+454	New	+$133K	﹤0.01%	2787